
Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.
Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.
Published: February 20th 2016 | Updated: